Skip to main content
Menu

Posts tagged with "Current Events"

  • Current Events

    Antiviral Theatrics?

    This will be a very rare link indeed for me, to the People’s Daily Twitter account out of China. I’d seen some clips like this before, but wasn’t sure of their provenance. This, though, is an official organ of the Chinese state – none more so – showing all sorts of white-fog-spraying devices being deployed… Read More
  • Current Events

    Harvard’s Chemistry Dept. Chairman in FBI Custody

    I suspect that most readers will have heard the news that Charles Lieber, nanoscale materials chemist and chair of Harvard’s chemistry department, was arrested yesterday by federal agents. He was accused of providing false statements to government agencies about his involvement with China’s “Thousand Talents” program and wit… Read More
  • Current Events

    Coronavirus

    As the world knows, we face an emerging virus threat in the Wuhan coronavirus (2019-nCoV) outbreak. The problem is, right now there are several important things that we don’t know about the situation. The mortality rate, the ease of human-human transmission, the rate of mutation of the virus (and how many strains we might be… Read More
  • Clinical Trials

    Opening the Lid on Sarepta’s Drug Approvals

    Let’s talk Sarepta. And FDA approval, because you can’t bring up that company without immediately starting a regulatory affairs argument. I was not happy when their initial exon-skipping therapy (Exondys, eteplirsen) for Duchenne muscular dystrophy was approved in 2016, because I thought that the efficacy data were simply not strong eno… Read More
  • Business and Markets

    Merck and Its Ransomware Problems in Court

    Well, this story is not specifically about the drug industry, although anything that shuts Merck down for two weeks, costs them around a billion dollars, and disrupts the US drug supply chain certainly has some relevance to it (!) I’m talking about the 2017 NotPetya ransomware attack. Merck was one of the high-profile corporate victims… Read More
  • Biological News

    Sydney Brenner, 1927-2019

    A scientific giant, Sydney Brenner has died at the age of 92. He was present at the beginning of molecular biology – while in the chemistry department at Oxford, he car-pooled with Dorothy Hodgkin, Leslie Orgel, Jack Dunitz and others over to Cambridge to see Watson and Crick’s new model for the structure of DNA… Read More
  • Current Events

    Back For More, 2019 Edition

    So, here we are. Today is the day that many people are heading back into offices and labs, feeling as if it’s been a month since they left, or perhaps like it’s been about two days. I can’t decide between those two myself. I’m not going to pull a Neil DeGrasse Tyson on everyone and… Read More
  • Current Events

    Sen. Warren’s Generic Drug Idea

    Here’s a proposal from Sen. Elizabeth Warren to have the government manufacture generic drugs directly. (I was traveling yesterday and wasn’t able to blog this then). It’s clear that there are some problems with parts of the generic drug system that we have, so my first thoughts were (1) whether Warren saw the same problems… Read More
  • Biological News

    After Such Knowledge

    So now we know more about the CRISPR human baby story. And it’s even worse than it looked. Let me recommend this report from Sharon Begley at Stat, from the International Human Genome Summit in Hong Kong, but it’s not going to make you happy to read it. It turns out that He Jiankui devoted quite… Read More
  • Biological News

    Born CRISPRed. Now What?

    Are there CRISPR-modified human babies now or not? I was waiting to write about this story in hope that it might get a little more clear, but so far that doesn’t seem to be happening. So here we go. What we know so far is that He Jiankui, a researcher from Shenzhen’s Southern University of Science… Read More
123...